Compound overview · Research
What Is Bromantane? Adamantane Actoprotector Research Overview
What is bromantane? An adamantane derivative studied as an “actoprotector”. This overview explains its structure, the gene-expression mechanism reported in rat studies, how it differs from classical stimulants in published research, and how labs handle this lipophilic compound.
Key takeaways
- Bromantane is N-(4-bromophenyl)adamantan-2-amine, C16H20BrN, about 306.2 g/mol.
- Rat studies report increased expression of tyrosine hydroxylase and DOPA decarboxylase, the dopamine-synthesis enzymes.
- It is an adamantane like amantadine and memantine; it is not approved by the EMA or FDA and is prohibited by WADA.
- Its bromine atom gives a distinctive 1:1 isotope pair in mass spectrometry.
What is bromantane?
Bromantane is N-(4-bromophenyl)adamantan-2-amine, an adamantane derivative developed at the Zakusov Institute of Pharmacology in Moscow and later registered in Russia as Ladasten. It belongs to a group of compounds described in the Russian literature as actoprotectors: substances studied for maintaining performance under physical or environmental stress in animal models.
Research use only. This overview summarises published laboratory and animal research. Baltic Peptides supplies this compound for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
Structure and specifications
| Property | Value |
|---|---|
| Chemical name | N-(4-Bromophenyl)adamantan-2-amine |
| Other names | Ladasten; bromantan; ADK-709 |
| Molecular formula | C16H20BrN |
| Molecular weight | ≈306.2 g/mol |
| Monoisotopic masses | 305.08 Da (79Br) / 307.08 Da (81Br) |
| CAS number | 87913-26-6 |
| Class | Adamantane derivative |
Bromine has two isotopes of almost equal abundance, so the mass spectrum shows a characteristic 1:1 pair of peaks two mass units apart, a built-in identity check when you read the COA.
Mechanism: dopamine synthesis via gene expression
Classical stimulants act mainly by releasing dopamine or blocking its reuptake. Published rat studies describe a different mechanism for bromantane: increased expression of tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC), the enzymes that make dopamine. Vakhitova et al. (2005) profiled gene-expression changes in rat brain after a single administration.
Mikhaylova et al. (2007) reported that bromantane differentially regulated TH mRNA and protein and L-DOPA and dopamine content across rat brain regions, and that in hippocampal slices it converted short-term into long-term potentiation through protein-synthesis- and dopamine-dependent mechanisms. Later work reported increased BDNF and NGF gene expression in rat striatum, hypothalamus and hippocampus.
Bromantane vs. classical stimulants (research context)
| Bromantane | Amphetamine-type stimulants | |
|---|---|---|
| Primary mechanism in models | ↑ TH / AADC expression | Dopamine release / reuptake block |
| Onset in rodent models | Gradual | Rapid |
| WADA status | Prohibited (stimulant) | Prohibited (stimulant) |
Main research areas
- Catecholamine synthesis: TH and AADC regulation in dopaminergic regions.
- Synaptic plasticity: hippocampal LTP models.
- Actoprotector research: performance under heat, hypoxia and fatigue in rodents.
- Anti-doping science: detection methods, given its history at the 1996 Olympics.
Handling bromantane in the lab
Bromantane is supplied lyophilised (or as a crystalline solid) and is most stable kept dry, sealed and cold. Standard laboratory practice: store long-term at -20 °C, protect from light and moisture, let vials reach room temperature before opening, and prepare solutions fresh in an organic solvent such as DMSO or ethanol first, because it is practically insoluble in water; dilute into buffer afterwards. See our guide to storing peptides in the lab for the full routine, and our COA reading guide for how to check the batch report.
Bromantane for research in Europe
Baltic Peptides ships bromantane from Lithuania with tracked delivery across the EU, so orders to Germany, France, the Netherlands, Poland, the Nordics and the Baltics stay inside one customs area. Every batch is tested by Janoshik Analytical before release and published on our COA page. View the bromantane product page for current batches and formats, or see EU shipping for delivery times.
Sources and further reading
- Mikhaylova M. et al. (2007). The effects of ladasten on dopaminergic neurotransmission and hippocampal synaptic plasticity in rats. Neuropharmacology 53(5):601-608. PubMed
- Vakhitova Y.V. et al. (2005). The effect of ladasten on gene expression in the rat brain. Dokl Biochem Biophys. PubMed
- Bromantane (Wikipedia overview).
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article explains analytical testing and is for educational purposes only.
FAQ
Common questions
What is bromantane?
How is bromantane different from stimulants in research?
Why does bromantane show two peaks in mass spectrometry?
Is bromantane soluble in water?
Is bromantane allowed in sport?
Keep reading
Related reading
Bromantane
Current batches, formats and the COA for Bromantane.
How to read a peptide COA
The 9-step checklist for any certificate of analysis.
How to store peptides in the lab
Storage and handling for lyophilised research compounds.
Research-grade Bromantane, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
